In This Section

Abstracts

EB 2018 Abstracts

Submit Late-Breaking Abstract

We encourage submission of abstracts to ASPET topic categories in all areas of pharmacology detailing your latest work. ASPET regular members can both submit their own work or sponsor the work of graduate students, undergraduates, and non-members.

Travel award and poster competition eligibility is based on student and postdoc submission to ASPET topic categories.

 

Hear why you should submit your abstract in this video from EB 2018.

Abstract Deadline

Now accepting Late-Breaking Abstract submissions until Wednesday, January 30.

Abstracts not received by November 18, 2018 will not be included in the regular program. After November 18th you will need to apply for a Late-Breaking Abstract with the higher submission processing fee.

Notifications about acceptance of abstracts submitted by November 18th, will be sent in early February. Notifications about acceptance of Late-Breaking abstracts will be sent in early March.

Submit your research to an ASPET topic category

How to be considered for ASPET Oral Presentations

Abstracts submitted by November 18th by students and postdocs may also be considered for an oral presentation in related symposia, division platform sessions, or the ASPET Daily Datablitz session. If selected for oral presentation, you will also be scheduled to present a poster in the EB exhibit/poster hall.

How to be considered for an ASPET Travel Award

Eligible students and postdocs must submit their work through EB to any ASPET category below AND complete the related ASPET application forms. Applications for ASPET travel awards close on Sunday, November 18, 2018.

How to be considered for an ASPET Poster Award

Eligible students and postdocs must submit their work through EB to any ASPET category below AND complete the related ASPET application forms. Applications for ASPET poster awards close on Sunday, November 18, 2018.

Criteria for Abstract Acceptance

Abstracts submitted for consideration will be reviewed by the ASPET Program Committee.  For acceptance for presentation and publication, abstracts must comply with the instructions and scientific integrity policy as outlined by the Experimental Biology meeting as well as meet the ASPET criteria below:

  1. Scientific Merit (original concept, improvement of previous idea, expands the field)
  2. Technical Quality (there are no major design or analysis issues)
  3. Abstract is Complete (contains a clear and satisfactory Objective/Aim/Hypothesis, Design/Approach/Methods, Results, and Conclusion)
  4. Relevance (contributes to improvement in scientific understanding)
  5. Originality (no concerns about scientific integrity/plagiarism)
  6. Language (satisfactory grammar/style and organization)

There is no guarantee that one’s abstract will be accepted or published.

Topic Categories

Late-Breaking Abstract Topics

300-ASPET

Cancer Pharmacology

301-ASPET

Cardiovascular Pharmacology (CVP)

302-ASPET

Cellular and Molecular Pharmacology

303-ASPET

Central Nervous System Pharmacology

304-ASPET

Drug Discovery and Development

305-ASPET

Drug Metabolism and Disposition (DVD)

306-ASPET

Pharmacogenomics and Translational Pharmacology

307-ASPET

Pharmacology Education

308-ASPET

Toxicology

309-ASPET

Pharmacology – Other

 

Cancer Pharmacology

3000-ASPET

Cancer Models

3001-ASPET

Drug Targets in Cancer

3002-ASPET

Anticancer Drug Response

3003-ASPET

Cancer Cell Signaling

3004-ASPET

Cancer Immunotherapy

 

Cardiovascular Pharmacology (CVP)

3005-ASPET

Cardiovascular Pharmacology

3006-ASPET

Vascular Pharmacology

3007-ASPET

Cardiac Pharmacology

3008-ASPET

Renal Pharmacology

3009-ASPET

Hypertension

3010-ASPET

Diabetes and Cardiovascular Disease

 

Cellular and Molecular Pharmacology

3011-ASPET

Gene Expression/Regulation

3012-ASPET

Omics / Big Data

3013-ASPET

Signal Transduction - General

3014-ASPET

Signal Transduction - G Proteins/GPCRs

3015-ASPET

Signal Transduction - Ion Channels

3016-ASPET

Signal Transduction - Kinases/Phosphatases/RTKs

3017-ASPET

Signal Transduction - Second Messenger Systems

3018-ASPET

Signal Transduction - Other Receptors

3019-ASPET

Mechanisms of Cell Injury/Death

3020-ASPET

Oxidative Stress

3021-ASPET

Mitochondrial Pharmacology & Toxicology

 

Central Nervous System Pharmacology

3022-ASPET

Behavioral Pharmacology

3023-ASPET

Drugs of Abuse and Addiction

3024-ASPET

Neuropharmacology

3025-ASPET

Biogenic Amines

3026-ASPET

CNS Transporters and Channels

3027-ASPET

Neuropharmacology Postdoc Showcase

 

Drug Discovery and Development

3028-ASPET

Drug Discovery and Development

 

Drug Metabolism and Disposition (DMD)

3029-ASPET

DMD - General

3030-ASPET

DMD - Pharmacokinetics/Modeling

3031-ASPET

DMD - Metabolic Enzymes

3032-ASPET

DMD - Transporters

3033-ASPET

DMD - Transcription Regulation

 

Pharmacogenomics and Translational Pharmacology

3034-ASPET

Translational Research

3035-ASPET

Clinical Pharmacology

3036-ASPET

Preclinical Pharmacology

3037-ASPET

Metabolic Pharmacology

3038-ASPET

Quantitative Systems / Precision Medicine

3039-ASPET

Regenerative Pharmacology

3040-ASPET

GI Pharmacology

3041-ASPET

Translational and Clinical Pharmacology Trainee Showcase

 

Pharmacology Education

3042-ASPET

Pharmacology Education

 

Toxicology

3043-ASPET

Biochemical/Mechanistic Toxicology

3044-ASPET

Organ Toxicology

3045-ASPET

Neurotoxicology

3046-ASPET

In Vitro Toxicology

3047-ASPET

Inflammation and Tissue Injury

3048-ASPET

Natural Products

 

Pharmacology - Other

3049-ASPET

Pharmacology - Microbiome

3050-ASPET

Pharmacology - All Other

 

Last Updated: December 4, 2018
Key Dates
November 28

Late-Breaking Abstract Submissions open

January 30

Late-Breaking Abstract Submissions due

February 5

Registration discounts end today

March 13

Discounted Hotel Rate Deadline

March 20

Advance Registration Deadline

April 6

ASPET Business Meeting and Awards Presentation

April 6-9

ASPET Annual Meeting at EB 2019

Thank you to our Annual Meeting partners:

jpet_banner
molpharm_banner
dmd_banner
pharmrev_banner
PR & P